Isuprel (Valeant Pharmaceuticals North America LLC)


Welcome to the PulseAid listing for the Isuprel drug offered from Valeant Pharmaceuticals North America LLC. This Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Valeant Pharmaceuticals North America LLC
NON-PROPRIETARY NAME: Isoproterenol hydrochloride
SUBSTANCE NAME: ISOPROTERENOL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC]
ROUTE: INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-12-01
END MARKETING DATE: 0000-00-00


Isuprel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIsuprel from Valeant Pharmaceuticals North America LLC
LABELER NAME: Valeant Pharmaceuticals North America LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 0.2(mg/mL)
START MARKETING DATE: 2013-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0187-4330_9b560894-45f2-4286-b9fd-8bfeb6c6a272
PRODUCT NDC: 0187-4330
APPLICATION NUMBER: NDA010515

Other ISOPROTERENOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthIsuprel
Hospira, Inc.Isuprel
Nexus Pharmaceuticals IncIsoproterenol Hydrochloride
Valeant Pharmaceuticals North America LLCIsuprel